Follow this innovation
[ via 
] [?]
Method for Replacing Hair Cells and Spiral Ganglia Neurons to Restore Hearing Loss
University of California System: University of California, Davis - UC Davis
posted on 06/19/2009
Neural Stem Cells as Therapeutic Agents for the Treatment of Hearing Loss
Suggested Uses
This method has therapeutic potential for treatment of hearing loss.
Advantages
Most forms of sensorineural hearing loss result from irreversible damage of cochlear hair cells which is followed by degeneration of target-deprived spiral ganglia neurons (SGNs). Secondary degeneration of SGNs could severely compromise the efforts to rehabilitate hearing impaired patients with cochlear implants or hair cell regeneration. However, there is limited availability of newly generated SGNs in humans and biological implantation of cells is not therapeutically inefficacious.
UC Davis researchers have:
- discovered both neural stem cells and epithelial cells covered with cilia. The epithelial cells physically and biochemically resemble hair cells.
- demonstrated epithelial cells can form synapses with SGNs and integrate into whole dissected cochleas. The neural stem cells from the lateral ventricle can develop into neurons that function similarly to SGNs and form working synapses. Adult stem cells, therefore show potential as therapeutic agents for treatment of hearing loss.
Detailed Description
Ten percent of the world’s population suffers from hearing loss due to damaged hair cells of the inner ear. Hair cells supply signals that promote the survival of spiral ganglia neurons (SGNs), the next link in the sonic signaling chain. Once the hair cells die, so do the SGNs. Hair cells regenerate at an extremely low rate. Thus, a cell replacement stratagem may offer a more immediate therapy due to the permanent loss of hair cells and SGNs. Researchers at the University of California, Davis have discovered the existence of a source of replacement cells for both hair cells and SGNs in the lateral wall of the lateral ventricle that can serve as biological implants for the deaf and hard of hearing.
File Number: 11180
| Patent Number(s): | WO100629059 |
|---|---|
| Copyright: | ©2009-2010, The Regents of the University of California |
This innovation currently is not available for online licensing. Please contact Rajagopal Gururajan at University of California System: University of California, Davis - UC Davis for more information.
request more info
ProfileFind more innovations
